Abstract
Background
For relief of bowel obstruction in left-sided obstructive colon cancer (LSOCC), a self-expandable metal stent (SEMS) or decompressing stoma (DS) can be placed. In a curative setting, these two strategies have been extensively studied as a bridge to elective resection. Guidelines recommend SEMS as the preferred option in the palliative setting, but adherence in daily practice is unknown. Therefore, this study aimed to gain more insight into patients with LSOCC who received palliative treatment with SEMS or DS at a national level.
Methods
A retrospective population-based cohort study was conducted in the Netherlands. Data from the Netherlands Cancer Registry (NCR) on all patients with LSOCC treated with DS or SEMS not followed by resection of the primary tumour between January 1, 2015, and December 31, 2019, were analysed. Type of treatment (DS or SEMS) for different clinical scenarios, was the main outcome of this study, and was also evaluated over the years (2015–2019).
Results
Palliative treatment with SEMS or DS for LSOCC was performed in 1077 patients, of whom 79.2% had metastatic disease (M1). Patients without metastatic disease (M0) were older (≥ 80 years M0 67.4%, M1 25.3%, P < 0.001), had a worse clinical condition (ASA III 51.4% versus 36.37%, ASA IV-V 13.3% versus 4.0% P < 0.001) and presented with higher tumour stage (cT4 55.4% versus 33.5%, % P < 0.001). DS was performed in 91.5% of the patients and SEMS in 8.5%. The proportion of DS did not significantly differ between patients with M1 and M0 (91.8% vs. 90.2% respectively, P = 0.525). No increase in SEMS application was observed over the years, with a stable overall proportion of DS of 91–92% per year. In the multivariable analyses, ninety-day mortality and overall survival were not significantly different between SEMS and DS.
Conclusions
This study revealed that DS was the primary treatment modality for palliative management of LSOCC in the Netherlands between 2015 and 2019, while the guidelines recommended SEMS as preferred treatment. For patients with LSOCC eligible for stenting in the palliative setting, SEMS placement should become more available and accessible as the preferred treatment option, to avoid a stoma in the terminal phase of life.
Similar content being viewed by others
Data Availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- LSOCC:
-
Left-sided obstructive colon cancer
- SEMS:
-
Self-expandable metal stent
- DS:
-
Decompressing stoma
- NCR:
-
Netherlands Cancer Registry
- ASA:
-
American Society of Anaesthesiologists
- OR:
-
Odds ratio
- 95% CI:
-
95% confidence interval
- HR:
-
Hazard Ratio
- M1:
-
Patients with metastatic disease
- M0:
-
Patients without metastatic disease
References
Amelung FJ, Burghgraef TA, Tanis PJ, van Hooft JE, Ter Borg F, Siersema PD, et al. Critical appraisal of oncological safety of stent as bridge to Surgery in left-sided obstructing colon Cancer; a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2018;131:66–75.
Tan L, Liu ZL, Ran MN, Tang LH, Pu YJ, Liu YL, et al. Comparison of the prognosis of four different treatment strategies for acute left malignant colonic obstruction: a systematic review and network meta-analysis. World J Emerg Surg. 2021;16(1):11.
Faragher IG, Chaitowitz IM, Stupart DA. Long-term results of palliative stenting or Surgery for incurable obstructing colon Cancer. Colorectal Dis. 2008;10(7):668–72.
Veld JV, Amelung FJ, Borstlap WAA, van Halsema EE, Consten ECJ, Siersema PD, et al. Comparison of Decompressing Stoma vs Stent as a bridge to Surgery for left-sided obstructive Colon Cancer. JAMA Surg. 2020;155(3):206–15.
Liao C, Qin Y. Factors associated with stoma quality of life among stoma patients. Int J Nurs Sci. 2014;1(2):196–201.
Silva JO, Gomes P, Gonçalves D, Viana C, Nogueira F, Goulart A, et al. Quality of life (QoL) among Ostomized patients – a cross-sectional study using stoma-care QoL questionnaire about the influence of some clinical and demographic data on patients’ QoL. J Coloproctology. 2019;39(1):48–55.
Young CJ, De-Loyde KJ, Young JM, Solomon MJ, Chew EH, Byrne CM, et al. Improving quality of life for people with Incurable large-bowel obstruction: Randomized Control Trial of Colonic stent insertion. Dis Colon Rectum. 2015;58(9):838–49.
Suzuki H, Tsujinaka S, Sato Y, Miura T, Shibata C. Oncologic impact of colonic stents for obstructive left-sided colon Cancer. World J Clin Oncol. 2023;14(1):1–12.
van Halsema EE, van Hooft JE, Small AJ, Baron TH, García-Cano J, Cheon JH, et al. Perforation in colorectal stenting: a meta-analysis and a search for risk factors. Gastrointest Endosc. 2014;79(6):970–82. e7; quiz 83.e2, 83.e5.
Veld J, Umans D, van Halsema E, Amelung F, Fernandes D, Lee MS, et al. Self-expandable metal stent (SEMS) placement or emergency Surgery as palliative treatment for obstructive Colorectal cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020;155:103110.
van Hooft JE, Veld JV, Arnold D, Beets-Tan RGH, Everett S, Götz M, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020. Endoscopy. 2020;52(5):389–407.
Richtlijn Colorectaal Carcinoom CRC. 2023 [Available from: https://richtlijnendatabase.nl/richtlijn/colorectaal_carcinoom_crc/primaire_behandeling_coloncarcinoom_bij_crc/acute_presentatie_cc_bij_crc.html.
Venderbosch S, de Wilt JH, Teerenstra S, Loosveld OJ, van Bochove A, Sinnige HA, et al. Prognostic value of resection of primary Tumor in patients with stage IV Colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol. 2011;18(12):3252–60.
van der Kruijssen DEW, Elias SG, Vink GR, van Rooijen KL, t, Lam-Boer J, Mol L et al. Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial. JAMA Surg. 2021;156(12):1093 – 101.
Kanemitsu Y, Shitara K, Mizusawa J, Hamaguchi T, Shida D, Komori K, et al. Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy alone for Colorectal Cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a Randomized Clinical Trial. J Clin Oncol. 2021;39(10):1098–107.
Zhang J, Zhu H, Yang W, Liu X, Zhang D, Jiang X, et al. Endoscopic stent versus diverting stoma as a bridge to Surgery for obstructive Colorectal cancer: a systematic review and meta-analysis. Langenbecks Arch Surg. 2022;407(8):3275–85.
Pattarajierapan S, Manomayangoon C, Tipsuwannakul P, Khomvilai S. Comparison of colonic stenting and stoma creation as palliative treatment for incurable malignant colonic obstruction. JGH Open. 2022;6(9):630–6.
Mangone L, Pinto C, Mancuso P, Ottone M, Bisceglia I, Chiaranda G, et al. Colon Cancer survival differs from right side to left side and lymph node harvest number matter. BMC Public Health. 2021;21(1):906.
Petrelli F, Tomasello G, Borgonovo K, Ghidini M, Turati L, Dallera P, et al. Prognostic survival Associated with Left-Sided vs right-sided Colon Cancer: a systematic review and Meta-analysis. JAMA Oncol. 2017;3(2):211–9.
Baran B, Mert Ozupek N, Yerli Tetik N, Acar E, Bekcioglu O, Baskin Y. Difference between left-sided and right-sided Colorectal Cancer: a focused review of literature. Gastroenterol Res. 2018;11(4):264–73.
Zhao XD, Cai BB, Cao RS, Shi RH. Palliative treatment for incurable malignant colorectal obstructions: a meta-analysis. World J Gastroenterol. 2013;19(33):5565–74.
Sloothaak DA, van den Berg MW, Dijkgraaf MG, Fockens P, Tanis PJ, van Hooft JE, et al. Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial. Br J Surg. 2014;101(13):1751–7.
van Hooft JE, Fockens P, Marinelli AW, Bossuyt PM, Bemelman WA. Premature closure of the Dutch stent-in I study. Lancet. 2006;368(9547):1573–4.
Veld JV, Amelung FJ, Borstlap WAA, van Eise E, Consten ECJ, Siersema PD, et al. Changes in management of left-sided obstructive Colon Cancer: National Practice and Guideline implementation. J Natl Compr Canc Netw. 2019;17(12):1512–20.
Acknowledgements
Not applicable.
Funding
None.
Author information
Authors and Affiliations
Contributions
JS and BZ analysed the data, JS, BZ and PT interpreted the patient data and wrote the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
Following Dutch national law, no ethical approval was required for this study.
Consent for Publication
Following Dutch national law, no informed consent was required for this study.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sijmons, J.M.L., Zamaray, B., Veld, J.V. et al. Relief of Obstruction in Left-Sided Obstructive Colon Cancer: Nationwide Analysis of Applied Treatment in the Palliative Setting. J Gastrointest Canc (2024). https://doi.org/10.1007/s12029-023-01010-6
Accepted:
Published:
DOI: https://doi.org/10.1007/s12029-023-01010-6